![[0626섹터분석] 2차전지·전기차, 자동차, 초전도체 등 테마주 강세](https://i-invdn-com.investing.com/news/external-images-thumbnails/picaf727b4888f77a8ab1e1a772c924892f.jpg)
선호 종목, 경제 이벤트, 팔로우하는 저자들의 글 업데이트를 받으시려면 회원가입을 해주세요.
무료 회원가입 이미 계정이 있으세요? 로그인
20.33
+0.29
+1.45%
엔비디아를 매도할 때인가요? 7월 추천 주식 목록받고 프로픽 AI에서 매도 타이밍 확인하기 🤔 50% 할인받기
BNY Mellon Research Growth Fund, Inc. Class Z (DREQX)
포토폴리오 추가/삭제
포트폴리오에 추가합니다
Dreyfus Research Growth Z
20.33
+0.29
+1.45%
DREQX 개요
이 페이지에서 BNY Mellon Research Growth Fund, Inc. Class Z에 대한 상세 프로필을_x0008_ 확인해 보세요. DREQX의 주요 관리, 총 자산, 투자 전략 및 연락처 정보에 대해 알아보세요.
연락처
최고 경영진
| 종목명 | 헤드라인 | 재직 시작연도 | 기간 |
|---|---|---|---|
| John R. Porter | Chief Investment Officer, Head of Equity | 2021 | now |
| 전기 | John is Newton’s chief investment officer and head of equity. John is responsible for overseeing all equity strategies. He is also lead portfolio manager for the US Small, Mid and Large Cap Growth Equity strategies. John joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, John was chief investment officer at Mellon Investments Incorporation. | ||
| Karen Miki Behr | - | 2021 | now |
| 전기 | Miki is a member of Newton’s equity opportunities team. In her current role, she is a portfolio manager on the growth funds. Miki joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Miki was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Previously, she was a research analyst with a focus on healthcare. Over her 14 years at the firm, she covered the consumer staples, consumer discretionary and healthcare sectors across EM, EAFE and the US. Prior to joining BNY Mellon, Miki worked at Leerink Swann & Co., a healthcare investment bank, advising venture capital and private equity firms as well as pharmaceutical, biotech and medical-device companies on strategic growth opportunities. | ||
| Monty Kori | Head of Growth Cyclical | 2019 | 2023 |
| 전기 | Monty is a member of Newton’s equity research team. In his current role, Monty heads up the growth cyclicals pod and is a senior research analyst on the global research team. He is also the portfolio manager of the US Manufacturing Fund. Monty joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Monty was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Monty was a sector portfolio manager at Fidelity Management & Research Company. He also served as a research analyst over his ten-year career at Fidelity. Previously, he was an associate at Stone Point Capital and an investment banking analyst at Morgan Stanley in New York. Monty has a BS in Electrical Engineering from Johns Hopkins University and an MBA from the Kellogg School of Management at Northwestern University. Joined Newton: 2021 Joined BNY Mellon group of companies: 2017 Joined industry: 2000 | ||
| Matt Jenkin | Research Analyst - Research & Development | 2019 | 2023 |
| 전기 | Matt is a member of Newton’s equity research team. Matt is responsible for covering the healthcare sector, specifically biopharmaceutical and medical-technology companies, and managing portfolios in the Smart Cures Innovation strategy. Matt joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Matt was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Matt served as a portfolio manager and analyst covering the healthcare sector at Balyasny Asset Management. Prior to that, he managed global long/short equity healthcare hedge funds and covered the pharmaceuticals, biotechnology and healthcare services industries at Lehman Brothers/Barclays Capital. Prior to joining the investment industry, Matt was a senior research scientist at SmithKline Beecham. Matt has a BS in Biology from Tulane University and an MBA from New York University. Joined Newton: 2021 Joined BNY Mellon group of companies: 2015 Joined industry: 2000 | ||
| Erik Swords | - | 2019 | 2022 |
| 전기 | Erik Swords with company 19 years, Industry experience 19 years Erik Swords is a head of global technology strategies on the fundamental thematic team at Voya Investment Management. He joined the firm following Voya’s integration of certain assets and teams comprising the substantial majority of Allianz Global Investors U.S. business, where he was a lead portfolio manager, managing director and led the U.S. global technology team. Prior to that, he worked at Newton Investment Management for 16 years, leading one of BNY Mellon’s largest technology strategies, along with several other thematic portfolios focused on technology and related sectors. Previously, he worked as a research analyst covering the software sector at Pilgrim Baxter Associates, Exis Capital Management and Credit Suisse First Boston Technology Group. Erik earned a BS in finance from Lehigh University. | ||
| Leigh N. Todd | Managing Director | 2019 | 2021 |
| 전기 | Ms. Todd is a managing director and senior research analyst at Mellon Investments Corporation ("Mellon") and joined Mellon's predecessor company in 2005. She was previously employed by Dreyfus, and affiliated BNY Mellon company, since 2001. Prior to that, she was employed by State Street Global Advisors. | ||
| Barry K. Mills | Lead Portfolio Manager | 2008 | 2019 |
| 전기 | Mills is a portfolio manager and senior managing analyst with Drefyus, his employer since 1999. Prior to joining the firm, he served as a portfolio manager with Phoenix Funds. From 1995-February 1997, he served as Director of Research for Howe and Rusling, Inc. | ||
| David M. Sealy | Portfolio Manager | 2008 | 2019 |
| 전기 | Sealy is a portfolio manager at Dreyfus. He is a vice president, portfolio manager and research analyst at The Boston Company Asset Management, LLC, an affiliate of Dreyfus, where he has been employed since June 2005. He also has been employed by Dreyfus since May 1997. | ||
| Elizabeth Slover | Director/ Portfolio Manager | 2005 | 2019 |
| 전기 | Elizabeth is the Director of The Boston Company’s Global Research Team, overseeing research for the U.S., EAFE and Emerging Markets. Elizabeth is also a Portfolio Manager on the US Large Cap Growth Equity strategy. Before joining The Boston Company, Elizabeth was with Chancellor LGT Asset Management (now Invesco), where she worked for the Director of Equities, responsible for managing the Equity Research Group. Before joining Chancellor, Elizabeth was in the Equity Research Department of Smith Barney, where she worked for the Chief Investment Strategist. She received a BA in Political Science from Union College. | ||
| Martin D. Stephan | Vice President, Portfolio Manager | 2006 | 2008 |
| 전기 | Stephen is vice president and portfolio manager with The Boston Company Asset Management LLC. He holds the Chartered Financial Analyst designation. | ||
고객님의 BNY Mellon Research Growth Fund, Inc. Class Z에 대한 생각을 적어 주십시오.
이 차트를 삭제하시겠습니까?
삭제 취소
첨부된 차트를 새 차트로 교체할까요?
교체 취소
의견 지침
의견에 차트 첨부하기
차단 확인
%USER_NAME%(을)를 정말로 차단하시겠습니까?
그렇게 하면, 귀하와 %USER_NAME%(은)는 서로의 Investing.com 게시물을 볼 수 없습니다.
%USER_NAME%(은)는 차단 명단에 추가되었습니다.
방금 이 사람을 차단해제하였으므로 48시간 이후에 차단을 재개할 수 있습니다.
이 의견 보고하기
나는 이 의견이 다음과 같다고 생각합니다:
의견에 깃발 표시됨
감사합니다!
귀하의 보고는 검토를 위해 조정자에게 보내졌습니다.